Stephen B Baylin Selected Research

Stephen B Baylin Research Topics

Disease

118	Neoplasms (Cancer) 03/2024 - 01/2002
18	Colorectal Neoplasms (Colorectal Cancer) 01/2023 - 06/2002
15	Colonic Neoplasms (Colon Cancer) 03/2024 - 06/2004
12	Ovarian Neoplasms (Ovarian Cancer) 01/2022 - 08/2015
12	Breast Neoplasms (Breast Cancer) 11/2019 - 04/2003
11	Lung Neoplasms (Lung Cancer) 10/2021 - 11/2003
10	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 07/2023 - 06/2006
10	Carcinogenesis 01/2023 - 06/2003
5	Carcinoma (Carcinomatosis) 01/2023 - 02/2007
5	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022 - 07/2005
5	COVID-19 01/2022 - 07/2021
4	Hematologic Neoplasms (Hematological Malignancy) 10/2021 - 12/2005
4	Inflammation (Inflammations) 01/2021 - 03/2011
4	Testicular Neoplasms (Testicular Cancer) 01/2020 - 02/2014
4	Adenocarcinoma 01/2016 - 08/2003
3	Infections 01/2022 - 08/2021
3	Neoplasm Metastasis (Metastasis) 01/2020 - 07/2005
3	Melanoma (Melanoma, Malignant) 04/2016 - 06/2010
2	Adenocarcinoma of Lung 07/2023 - 01/2011
2	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 12/2022 - 04/2013
2	Bites and Stings (Sting) 01/2022 - 01/2020
2	Leukemia 01/2022 - 07/2005
2	Ovarian Epithelial Carcinoma 10/2021 - 12/2017
2	Triple Negative Breast Neoplasms 01/2018 - 06/2017
2	Lymphoma (Lymphomas) 09/2016 - 07/2005
2	Glioma (Gliomas) 06/2015 - 10/2013
2	Adenoma (Adenomas) 10/2011 - 06/2009
1	Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic) 12/2022
1	Cytopenia 12/2022
1	Granuloma 10/2021
1	Sarcoma (Soft Tissue Sarcoma) 01/2020

Drug/Important Bio-Agent (IBA)

68	DNA (Deoxyribonucleic Acid)IBA 03/2024 - 01/2002
26	MethyltransferasesIBA 03/2024 - 01/2002
20	Proteins (Proteins, Gene)FDA Link 01/2022 - 03/2004
20	ChromatinIBA 10/2021 - 06/2002
17	Biomarkers (Surrogate Marker)IBA 11/2019 - 01/2006
12	Decitabine FDA Link 01/2022 - 11/2003
11	Azacitidine (5 Azacytidine)FDA Link 10/2021 - 12/2005
9	Histones (Histone)IBA 03/2024 - 11/2003
9	Immune Checkpoint InhibitorsIBA 01/2023 - 04/2016
8	Transcription Factors (Transcription Factor)IBA 02/2024 - 08/2003
8	Histone Deacetylase InhibitorsIBA 10/2021 - 11/2003
7	InterferonsIBA 07/2023 - 02/2014
7	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2022 - 10/2016
6	MicroRNAs (MicroRNA)IBA 10/2021 - 04/2008
5	Histone Deacetylases (Histone Deacetylase)IBA 01/2018 - 06/2002
5	EnzymesIBA 01/2017 - 04/2002
4	Messenger RNA (mRNA)IBA 01/2022 - 06/2015
4	RNA (Ribonucleic Acid)IBA 01/2022 - 08/2005
4	AntigensIBA 01/2020 - 02/2014
4	Sirtuin 1IBA 01/2018 - 11/2005
4	entinostat (MS 275)IBA 06/2017 - 01/2011
3	Calcibiotic Root Canal SealerIBA 01/2023 - 06/2009
3	guadecitabineIBA 01/2023 - 01/2018
3	Protein Isoforms (Isoforms)IBA 01/2022 - 11/2017
3	talazoparibIBA 01/2022 - 01/2018
3	Antiviral Agents (Antivirals)IBA 10/2021 - 10/2018
3	A-Form DNA (A-DNA)IBA 06/2017 - 12/2009
3	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2016 - 03/2011
3	Secreted Frizzled-Related ProteinsIBA 10/2011 - 04/2004
3	Cyclin-Dependent Kinase Inhibitor p16IBA 06/2010 - 04/2003
3	Small Interfering RNA (siRNA)IBA 04/2008 - 01/2006
2	atezolizumabIBA 01/2023 - 12/2022
2	PlatinumIBA 01/2022 - 01/2005
2	InflammasomesIBA 01/2022 - 01/2020
2	Recombinant DNA (Recombinant DNA Research)IBA 01/2022 - 07/2021
2	Irinotecan (Camptosar)FDA LinkGeneric 01/2020 - 01/2015
2	Histone MethyltransferasesIBA 10/2018 - 02/2014
2	Interferon Type IIBA 12/2017 - 08/2015
2	Estrogen ReceptorsIBA 06/2017 - 01/2013
2	Double-Stranded RNA (RNA, Double Stranded)IBA 08/2015 - 08/2005
2	trichostatin A (A 300)IBA 04/2014 - 02/2006
2	Tumor Biomarkers (Tumor Markers)IBA 01/2012 - 09/2007
2	CytosineIBA 12/2008 - 11/2003
2	Complementary DNA (cDNA)IBA 04/2004 - 06/2002
1	UbiquitinIBA 02/2024
1	CDX2 Transcription FactorIBA 02/2024
1	LigandsIBA 01/2023
1	TESIBA 01/2023
1	B7-H1 AntigenIBA 12/2022
1	Adenosine (Adenocard)FDA LinkGeneric 07/2022
1	ToyocamycinIBA 07/2022
1	RNA-Binding Proteins (RNA-Binding Protein)IBA 01/2022
1	Long Noncoding RNAIBA 01/2022
1	ElementsIBA 10/2021
1	CytidineIBA 10/2021
1	MutagensIBA 01/2021
1	tazemetostatIBA 01/2020
1	3-chloro-2,5,6-trimethylbenzoateIBA 01/2020
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2020
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 11/2019
1	PolyaminesIBA 01/2019
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2019
1	binimetinibIBA 11/2018
1	Transforming Growth Factor beta Receptors (TGF beta Receptors)IBA 11/2018

Therapy/Procedure

52	Therapeutics 03/2024 - 01/2004
8	Drug Therapy (Chemotherapy) 07/2022 - 01/2005
7	Immunotherapy 07/2023 - 04/2016
3	Aftercare (After-Treatment) 01/2023 - 04/2013
2	Investigational Therapies (Experimental Therapy) 01/2017 - 11/2013